|

Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

RECRUITINGN/ASponsored by Peking Union Medical College Hospital
Actively Recruiting
PhaseN/A
SponsorPeking Union Medical College Hospital
Started2024-08-06
Est. completion2025-12-31
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07288931

Summary

The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocytoma/paraganglioma (PPGL).

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients aged 18 to 80 years.
* Suspected or confirmed PPGL patients.

Exclusion Criteria:

* Combined with other types of tumors.
* Severe liver or renal dysfunction (ALT/AST≥5 ULN, GFR\<30ml/min).
* Pregnant or breast-feeding women.
* Inability to perform PET/CT scans.

Conditions2

CancerPheochromocytoma/Paraganglioma (PPGL)

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.